Dr. McNeel will develop a career in patient-oriented translational research with an emphasis on the immunological treatment of patients with prostate cancer. The goal of this proposal is describe both a career training and mentoring plan through which he will receive training in the proper conduct of human subjects research, as well as a translational research plan leading to the conduct of a human vaccine trial for patients with prostate cancer. As part of his career development plan, Dr. McNeel will complete the UW Clinical Investigator Preparatory Pathway (CIPP). This program is an individualized program proviiding didactic and mentored training in the areas of biostatistics and clinical study design, clinical research ethics, leadership and management skills, presentation and teaching skills, scientific writing skills, and expertise within a specific research domain. In addition, he will be mentored directly by Dr. Mark Albertini, a leader in the field of DNA vaccien clinical trials research. His academic and career progress will be followed quarterly by the CIPP Executive Committee as well as Dr. McNeel's faculty mentoring committee at the University of Wisconsin (composed of Drs. Albertini, Sondel, Bryan and Bailey). The other part of this proposal describes a 5-year translational research plan in which Dr. McNeel proposes three aims: 1) to identify the immunological mediators of prostate tissue destruction in a rat model fo inflammatory prostatistics; 2) to identify proteins immunologically recognized in patients with chronic inflammatory prostatis; and 3) to determine in a human clinical vaccine trial the safety and immunological efficacy of a DNA-based vaccine in patients with advanced stage prostate cancer. This clinical trial will target the same antigen, prostatic acid phosphatase, and using the same DNA immunization techniques used to elicit prostatis in the rodent model. This trial will serve as a platform and model for clinical trial evaluation of antigens identified in the second aim of the proposal.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23RR016489-01A1
Application #
6531352
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Wilde, David B
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
1
Fiscal Year
2002
Total Cost
$138,290
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Tian, Kai; Shi, Ruicheng; Gu, Amy et al. (2017) Polycationic Probe-Guided Nanopore Single-Molecule Counter for Selective miRNA Detection. Methods Mol Biol 1632:255-268
Kang, Insoon; Wang, Yong; Reagan, Corbin et al. (2013) Designing DNA interstrand lock for locus-specific methylation detection in a nanopore. Sci Rep 3:2381
Tian, Kai; He, Zhaojian; Wang, Yong et al. (2013) Designing a polycationic probe for simultaneous enrichment and detection of microRNAs in a nanopore. ACS Nano 7:3962-9
Gu, Li-Qun; Wang, Yong (2013) Nanopore single-molecule detection of circulating microRNAs. Methods Mol Biol 1024:255-68
Gu, Li-Qun; Wanunu, Meni; Wang, Michael X et al. (2012) Detection of miRNAs with a nanopore single-molecule counter. Expert Rev Mol Diagn 12:573-84
Shim, Jiwook; Gu, Li-Qun (2012) Single-molecule investigation of G-quadruplex using a nanopore sensor. Methods 57:40-6
Tan, Qiulin; Ritzo, Brandon; Tian, Kai et al. (2012) Tuning the tetraethylammonium sensitivity of potassium channel Kcv by subunit combination. J Gen Physiol 139:295-304
Otvos Jr, Laszlo; Kovalszky, Ilona; Scolaro, Laura et al. (2011) Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation. Biopolymers 96:117-25
Maricque, Brett B; Eickhoff, Jens C; McNeel, Douglas G (2011) Antibody responses to prostate-associated antigens in patients with prostatitis and prostate cancer. Prostate 71:134-46
Olson, Brian M; McNeel, Douglas G (2011) CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells. Cancer Immunol Immunother 60:781-92

Showing the most recent 10 out of 44 publications